Results 121 to 130 of about 291,345 (345)

Antitumor Activity of Pembrolizumab in Biomarker-Unselected Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma: Results From the Phase Ib KEYNOTE-012 Expansion Cohort. [PDF]

open access: yes, 2016
Purpose Treatment with pembrolizumab, an anti-programmed death-1 antibody, at 10 mg/kg administered once every 2 weeks, displayed durable antitumor activity in programmed death-ligand 1 (PD-L1) -positive recurrent and/or metastatic (R/M) head and neck ...
Berger, Raanan   +21 more
core   +2 more sources

Abruzzo

open access: yesFarmeconomia: Health Economics and Therapeutic Pathways, 2012
In Abruzzo region 71% of women (aged 24-64) are screened regularly, meaning every 3 years. The analysis on cross-protective activity exercised by bivalent and quadrivalent vaccines shows that the bivalent vaccine could prevent more pre-cancerous lesions ...
Roberto Gasparini   +9 more
doaj   +1 more source

PH, NOT PCO2, DECREASES HYPOXIC PULMONARYVASOCONSTRICTION (HPV) IN THE NEWBORN LAMB [PDF]

open access: bronze, 1984
Michael D. Schreiber   +2 more
openalex   +1 more source

A New Orthotopic Mouse Model of Laryngeal Squamous Cell Carcinoma

open access: yesHead &Neck, EarlyView.
ABSTRACT Background The aim of this study is to establish a novel and reproducible orthotopic mouse model, aiming to facilitate research related to laryngeal cancer. Methods Implantation of mouse squamous cell carcinoma cell line, Meer‐LUC, into the larynx of C57BL/6 mice (n = 16).
Junrong Wang   +10 more
wiley   +1 more source

Regione “Test”

open access: yesFarmeconomia: Health Economics and Therapeutic Pathways, 2012
In “Test” region 75% of women (aged 24-64) are screened regularly, meaning every 3 years. A cost-effectiveness analysis shows that, considering regional tariffs, the multiple cohort (12-year-old + 25-year-old women) vaccination strategy with a 50 ...
Roberto Gasparini   +9 more
doaj   +1 more source

Application of a Saliva‐Based Liquid Biopsy for the Detection of HPV in Patients With Oral Cavity Squamous Cell Carcinoma (OCSCC)

open access: yesHead &Neck, EarlyView.
ABSTRACT Background Human papilloma virus (HPV) is a DNA virus capable of infecting mucous membranes. In most cases, the infection is cleared by the immune system, but a prolonged exposure to HPV can progress to cancer. 40%–60% of head and neck squamous cell carcinomas (HNSCC) are linked to HPV, which is considered a risk factor especially among young ...
Michela Bulfoni   +12 more
wiley   +1 more source

Oral human papillomavirus (HPV) infection in men who have sex with men: prevalence and lack of anogenital concordance. [PDF]

open access: yes, 2015
To estimate the prevalence of oral detectable human papillomavirus (HPV) DNA in HIV-negative men who have sex with men (MSM) attending a sexual health clinic in London and concordance with anogenital HPV infection.
Beddows, S   +8 more
core  

EFFECTS OF FLOW ON HYPOXIC PULMONARY VASOCONSTRICTION (HPV) [PDF]

open access: bronze, 1984
C. Marshall, S. D. Kim, B. E. Marshall
openalex   +1 more source

Does Modified 5‐Item Frailty Index Correlate With Survival in Oropharyngeal Squamous Cell Carcinoma?

open access: yesHead &Neck, EarlyView.
ABSTRACT Introduction Oropharyngeal squamous cell cancer (OPSCC) is a common subtype of head and neck cancer. It is generally stratified into high, intermediate, and low risk prognostic groups on the basis of HPV (human papillomavirus) status and smoking history (Ang risk stratification).
Marta Chmielecka   +10 more
wiley   +1 more source

Home - About - Disclaimer - Privacy